Literature DB >> 2546429

Mechanism for human papillomavirus transmission at birth.

T V Sedlacek1, S Lindheim, C Eder, L Hasty, M Woodland, A Ludomirsky, R F Rando.   

Abstract

We attempted to investigate mechanisms, in addition to sexual contact, by which human papillomaviruses associated with anogenital tract lesions could be transmitted. Samples of exfoliated cervical cells were obtained from 45 pregnant women and were assayed by Southern blot hybridization analysis for the presence of human papillomavirus nucleic acids. Twenty-five of the 45 women had cells positive for human papillomavirus deoxyribonucleic acid. A neonatal nasopharyngeal aspirate was obtained at term and analyzed for the presence of human papillomavirus deoxyribonucleic acid. We documented the presence of human papillomavirus deoxyribonucleic acid in the oral pharyngeal cavity of the neonates in 15 of 45 nasopharyngeal samples analyzed. Amniotic fluid was obtained from 13 patients when their membranes were artificially ruptured. These samples were assayed for the presence of human papillomavirus deoxyribonucleic acid; two of the 13 amniotic fluid samples contained human papillomavirus deoxyribonucleic acid. The detection of human papillomavirus deoxyribonucleic acid in the oral cavity of neonates is indicative of a perinatal mechanism of viral transmission. The detection of human papillomavirus deoxyribonucleic acid in the amniotic fluid may suggest an in utero mechanism of transmission. However, problems encountered in collecting the amniotic fluid samples preclude us from definitive interpretation of these data.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2546429     DOI: 10.1016/0002-9378(89)90232-9

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  19 in total

1.  Vertical transmission of human papillomavirus in cytologically normal women.

Authors:  C Mazzatenta; M Fimiani; P Rubegni; L Andreassi; P Buffi; C Messina
Journal:  Genitourin Med       Date:  1996-12

Review 2.  5-FU for genital warts in non-immunocompromised individuals.

Authors:  Claudio S Batista; Alvaro N Atallah; Humberto Saconato; Edina Mk da Silva
Journal:  Cochrane Database Syst Rev       Date:  2010-04-14

Review 3.  Human papillomavirus in infants: transmission, prevalence, and persistence.

Authors:  Delese E LaCour; Connie Trimble
Journal:  J Pediatr Adolesc Gynecol       Date:  2011-05-20       Impact factor: 1.814

Review 4.  The role of the human papillomavirus in the pathogenesis of Schneiderian inverted papillomas: an analytic overview of the evidence.

Authors:  William Lawson; Nicolas F Schlecht; Margaret Brandwein-Gensler
Journal:  Head Neck Pathol       Date:  2008-04-23

5.  High-risk human papillomavirus in the oral cavity of women with cervical cancer, and their children.

Authors:  Rajan Saini; Tan P Khim; Sarah A Rahman; Mazian Ismail; Thean H Tang
Journal:  Virol J       Date:  2010-06-16       Impact factor: 4.099

Review 6.  Sexually transmitted diseases in sexually abused children: medical and legal implications.

Authors:  M R Hammerschlag
Journal:  Sex Transm Infect       Date:  1998-06       Impact factor: 3.519

Review 7.  Pathogenesis of genital HPV infection.

Authors:  A Schneider
Journal:  Genitourin Med       Date:  1993-06

8.  Possible non-sexual transmission of genital human papillomavirus infections in young women.

Authors:  C C Pao; P L Tsai; Y L Chang; T T Hsieh; J Y Jin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-03       Impact factor: 3.267

9.  Multicenter initiative seeking critical genes in respiratory papillomatosis.

Authors:  Farrel J Buchinsky; Craig S Derkay; Suzanne M Leal; Joseph Donfack; Garth D Ehrlich; J Christopher Post
Journal:  Laryngoscope       Date:  2004-02       Impact factor: 3.325

10.  Perinatal transmission of human papilomavirus DNA.

Authors:  Renato L Rombaldi; Eduardo P Serafini; Jovana Mandelli; Edineia Zimmermann; Kamille P Losquiavo
Journal:  Virol J       Date:  2009-06-21       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.